(Q40386207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Maurizio Federico

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Silvia Peretti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Katherina Pugliese

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

1 reference

10 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1185-1196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16095973%20AND%20SRC:MED&resulttype=core&format=json

Solid lipid nanoparticles for parenteral drug delivery.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Coming of age of lipid-based drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Targeting DNA to cells with basic fibroblast growth factor (FGF2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Cellular uptake of the tat protein from human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Intercellular trafficking and protein delivery by a herpesvirus structural protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Retroviral pseudotransduction for targeted cell manipulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Nucleic acid-independent retrovirus assembly can be driven by dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Particle-based vaccines for HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Structure--function relationships in HIV-1 Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Evidence for the association of Nef protein with HIV-2 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Properties of a chimeric simian-human immunodeficiency virus expressing an hybrid HIV-1 Nef/SIVmac Nef protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

The Nef protein of HIV-1 associates with rafts and primes T cells for activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Nef increases infectivity of HIV via lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Lipid rafts and HIV-1: from viral entry to assembly of progeny virions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

The division of endosymbiotic organelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

The promise of cancer vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

The proteolytic cleavage of human immunodeficiency virus type 1 Nef does not correlate with its ability to stimulate virion infectivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

7 January 2021

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

7 January 2021

Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

7 January 2021

gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

7 January 2021

Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.474

7 January 2021